<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200110046073N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-01</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of preoperative intravenous mannitol injection in reducing acute kidney injury following percutaneous nephrolithotomy</public_title>
      <acronym></acronym>
      <scientific_title>The effect of preoperative intravenous mannitol injection in reducing acute kidney injury following percutaneous nephrolithotomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-03-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45012</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: َAccording to a Balance block randomization table prepared for 150 patients with statistical software, 75 patients will be in case and the rest will be in the control group randomly. This table will be just given to the anesthesiologist who is the only person who knows the patient group. All patients who have the criteria of this study will be placed in one of the case or control group respectively as the come to the operating room according to the Balance block randomization table by the anesthesiologist . Each patient has a form with a number at the top which does not show the group of patient. All the data except for the group of the patients will be inserted to an SPSS form by one person and the group will be inserted in a 0 and 1 manner in another SPSS form by another person and then will be copied to the first SPSS form. 
Data analyser will not be informed of the group of patients and will know them as group 0 and 1. After analysis finnished, we will have access to the type of 0 and 1 group according to the person who inserted the data of group type in the SPSS form, Blinding description: Patients, data collector and analyzer, and the researcher will be all blinded to injection of mannitol. It will be done according to the balance block randomization table by Anesthesiologist.</study_design>
      <phase>3</phase>
      <hc_freetext>Acute kidney injury, Renal stone, Percutaneous nephrolithotomy (PCNL).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Interavenous injection of 25 grams of mannitol (125 cc of 20% mannitol Serum) in 75 patients candidated for percutaneous nephrolithotomy, 15 minutes before surgery. Intervention 2: Control group: Interavenous injection of 125 cc of Non mannitol Serum in 75 patients candidated for percutaneous nephrolithotomy, 15 minutes before surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All  data can potentially be shared after hiding patients identity

When:
18 months after article publication, data is available

To whom:
Only for researches in universities and academic institutions

Conditions:
No other condition is needed

Where to obtain:
Mohammadmehdi Atarod
00989120233308
dr.atarod@gmail.com

How to obtain:
After receiving an email based on the need to access the data of this article, respond will be sent within 30 work days

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kaveh Mehravaran</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vanak sq- Valiasr st- Valinejad st- Hasheminejad Kidney Center Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1969714713</zip>
        <telephone>+98 21 8864 4441</telephone>
        <email>Mehravarankaveh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kaveh Mehravarn</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vanak sq- Valiasr st- Valinejad st- Hasheminejad Kidney Center Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1969714713</zip>
        <telephone>+98 21 8864 4441</telephone>
        <email>Mehravarankaveh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with renal stone greater than 20 mm in diameter who are candidated for percutaneous nephrolithotomy.
Patients with proximal ureter stone greater than 20 mm in diameter who are candidated for percutaneous nephrolithotomy.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Heart failure
History of lung embolism
History of deep vein thrombosis
History of brain edema
History of intracranial hemorrhage
Respiratory edema
Anuria
History of digoxin consumption
History of Lithium consumption
History of allergy to mannitol
Electrolite imbalance
Coagolopathies</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N99.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Postprocedural (acute) (chronic) kidney failure</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Interavenous injection of 25 grams of mannitol (125 cc of 20% mannitol Serum) in 75 patients candidated for percutaneous nephrolithotomy, 15 minutes before surgery</i_keyword>
      <i_keyword>Control group: Interavenous injection of 125 cc of Non mannitol Serum in 75 patients candidated for percutaneous nephrolithotomy, 15 minutes before surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post percutaneous nephrolithotomy glomerular filtration rate changes. Timepoint: The day before surgery, 6 hours after surgery, 1, 2, and 14 days after surgery. Method of measurement: cockroft gault equation (based on serum creatinine level).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Post operative hemoglobin changes. Timepoint: The day before surgery, 6 hours after surgery, 1, 2, and 14 days after surgery. Method of measurement: Complete blood count.</sec_outcome>
      <sec_outcome>Post operative infection. Timepoint: The day before surgery, 6 hours after surgery, 1, 2, and 14 days after surgery. Method of measurement: Thermometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-24</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Vanak sq- Valiasr st- Valinejad st- Hasheminejad Kidney Center Hospital Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
